EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Drinking-water 4,4′-methylenedianiline establishes a longitudinally tractable mouse model of cholestatic liver injury

Takumi Iwasaka, Katsuhisa Morita, Iori Azuma, Tomoka Nakagawa, Eri Nakashima, Tomomi Kamei, Yuki Kato, Hiroyuki Kusuhara, Tadahaya Mizuno

Toxicological Sciences · 2026-11-02 · 209 (11)

DOI: 10.1093/toxsci/kfag142 ↗
AbstractBibliografische Angaben

Abstract

Abstract Longitudinal studies of liver injury require models that can be maintained with simple administration, low procedure-related stress, and acceptable survival. Drinking-water thioacetamide (TAA-DW) is useful for this purpose, but it mainly produces centrilobular hepatocellular injury. Few drinking-water models are available for cholestatic liver injury. Here, we tested whether 4,4′-methylenedianiline (MDA), a known bile-duct-damaging hepatotoxicant, can be used to build a practical drinking-water model of cholestatic liver injury in mice. Male C57BL/6JJcl mice received MDA in drinking water for up to 28 d. A route- and administration-schedule-matched TAA-DW model was used as a reference. Drinking-water MDA (MDA-DW) caused sustained ALT elevation without observed mortality under the tested regimen. Compared with TAA-DW, MDA-DW produced stronger cholestatic biochemical features, including increased ALP, TBIL, and TCHO. Histology showed bile duct hyperplasia with degeneration, periportal/peribiliary fibrosis, and scattered focal hepatocellular necrosis. Whole-slide image analysis supported the distinct lesion distribution between MDA-DW and TAA-DW. Early time-resolved multimodal profiling showed model-specific responses: MDA-DW showed ALT elevation around Days 2 to 3, increased CD8-positive T cells on Day 8, and enrichment of fibrinolysis-related gene sets, whereas TAA-DW showed a sharp early injury peak and transient eosinophil increase. Impact Statement: This study expands the range of drinking-water liver injury models by providing a low-mortality MDA-DW model with cholestatic liver injury. The model offers a simple platform for time-resolved studies of liver injury progression, tissue remodeling, and model-specific inflammatory responses.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →